| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/18/2013 | WO2013105608A1 P2x4 receptor antagonist |
| 07/18/2013 | WO2013076315A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides |
| 07/18/2013 | US20130184457 Method for the preparation of rivoraxaban |
| 07/18/2013 | US20130184278 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/18/2013 | US20130184277 Adamantyl diamide derivatives and uses of same |
| 07/18/2013 | US20130184275 Hydrazone modulators of cannabinoid receptors |
| 07/18/2013 | US20130184261 Pyridazinone derivatives |
| 07/18/2013 | US20130184260 Pyridazinone derivatives |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 07/18/2013 | US20130184256 New substituted glycinamides, process for their manufacture and use thereof as medicaments |
| 07/18/2013 | US20130184251 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
| 07/18/2013 | US20130184241 Naphthalene Derivative |
| 07/18/2013 | US20130184222 Therapeutically active compositions and their methods of use |
| 07/18/2013 | US20130183388 Novel IDO Inhibitors and Methods of Use Thereof |
| 07/17/2013 | EP2615088A1 Composition, synthesis and use of new substituted pyran and pterin compounds |
| 07/17/2013 | EP2615086A1 2,4-Diaminoquinazolines for the treatment of spinal muscular atrophy |
| 07/17/2013 | EP2615084A1 Prostaglandin d synthase inhibitory piperidine compounds |
| 07/17/2013 | CN103209976A 1-(heterocyclic carbonyl)-2-substituted pyrrolidines |
| 07/17/2013 | CN103209972A Xanthone compound and organic light-emitting device including the same |
| 07/17/2013 | CN103209960A Sulfonamide compounds useful as CYP17 inhibitors |
| 07/17/2013 | CN103204820A 3-triazolyl-substituted-1-propylene compound and synthetic method thereof |
| 07/17/2013 | CN103204818A Preparation method of multi-substituted quinazoline derivative |
| 07/17/2013 | CN103204813A Condensed imidazole derivatives as TRPV3 antagonist |
| 07/17/2013 | CN103204798A Aromatic amine derivative, its preparation method and organic electroluminescent device made through using it |
| 07/17/2013 | CN101998951B Acylthiourea compound or salt thereof, and use thereof |
| 07/17/2013 | CN101959880B A process for preparing eprosartan mesylate |
| 07/17/2013 | CN101743240B ((Phenyl)imidazolyl)methylheteroaryl compounds |
| 07/17/2013 | CN101663270B Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 07/17/2013 | CN101619056B Benzothiophene alkanol piperazine derivatives and use thereof as antidepressant medicaments |
| 07/17/2013 | CN101490036B Factor xa inhibitors |
| 07/17/2013 | CN101479008B Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol |
| 07/17/2013 | CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET |
| 07/16/2013 | US8487107 Biphenyl compounds useful as muscarinic receptor antagonists |
| 07/16/2013 | US8486986 Microbiocides |
| 07/16/2013 | US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders |
| 07/16/2013 | US8486971 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof |
| 07/16/2013 | CA2711508C Proline analogs as ligands for cannabinoid receptors |
| 07/16/2013 | CA2583983C Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/11/2013 | WO2013102936A1 N-(3-((diethylamino) methyl)-4-hydroxyphenyl)-n-(quinolin-4-yl) sulfonamides for the treatment of tuberculosis and process of preparation thereof |
| 07/11/2013 | WO2013102929A1 Novel compounds for treatment of diabetes, obesity or related disorders |
| 07/11/2013 | WO2013039785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 07/11/2013 | US20130178632 Transition-Metal-Catalyzed Carbon-Nitrogen and Carbon-Carbon Bond-Forming Reactions |
| 07/11/2013 | US20130178507 Substituted bicyclic hcv inhibitors |
| 07/11/2013 | US20130178502 Pyridine Compounds for Controlling Invertebrate Pests I |
| 07/11/2013 | US20130178499 Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors |
| 07/11/2013 | US20130177632 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 07/11/2013 | US20130177529 Pyrazole Compounds |
| 07/10/2013 | EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/10/2013 | EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 07/10/2013 | EP2612852A1 Theramutein modulators |
| 07/10/2013 | EP2611786A1 New compositions and methods for controlling nematode pests |
| 07/10/2013 | EP2611774A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors |
| 07/10/2013 | EP2611300A1 Substituted fused pyrimidinones and dihydropyrimidinones |
| 07/10/2013 | EP2611297A1 Fungicidal pyrazoles |
| 07/10/2013 | CN103201279A Compounds useful as modulators of TRPM8 |
| 07/10/2013 | CN103201273A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 07/10/2013 | CN103201267A Ampk-activating heterocyclic compounds and methods for using the same |
| 07/10/2013 | CN103193771A New use of drug of chain amide CCR5 (chemokine receptor) receptor antagonist |
| 07/10/2013 | CN103193761A 2-phenyl-6-azolylpyridine-based ligand and group viii transition metal complex |
| 07/10/2013 | CN103193760A Sulfonyl-containing compound, organic light-emitting device (OLED) adopting same and preparation method of OLED |
| 07/10/2013 | CN103193754A 7-acyl-15-oxo-spiraea lactone derivative as well as preparation method and applications thereof |
| 07/10/2013 | CN103193718A A 4-substituted derivative of 5-bromopyrimidine and a preparation method thereof |
| 07/10/2013 | CN103193717A Phenylene bipyrimidinyl compound, as well as synthesis method and application thereof |
| 07/10/2013 | CN103193697A Light-emitting device material and light-emitting device |
| 07/10/2013 | CN103193569A Method for synthesis of acetal/ketal in presence of acidic ionic liquid as catalyst? |
| 07/10/2013 | CN101687841B Benzimidazole derivatives |
| 07/10/2013 | CN101253166B Sulfonamide compound |
| 07/09/2013 | US8481539 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 07/09/2013 | CA2761440C Fredericamycin derivatives |
| 07/09/2013 | CA2520323C Tie-2 modulators and methods of use |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013098746A1 Fullerenes functionalized with thienylene for photovoltaics |
| 07/04/2013 | WO2013097947A1 Pipecolate-sulfonamides for treatment of psychiatric disorders |
| 07/04/2013 | WO2013051024A3 Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (ltc4) |
| 07/04/2013 | US20130172550 P2x4 receptor antagonist |
| 07/04/2013 | US20130172390 Haloalkyl-Substituted Amides as Insecticides and Acaricides |
| 07/04/2013 | US20130172365 Arylosulfonamides for the treatment of cns diseases |
| 07/04/2013 | US20130172354 Heteroaryl compounds and their uses |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/04/2013 | US20130172339 Sulfonamide compounds |
| 07/04/2013 | US20130172310 Benzamides and related inhibitors of factor xa |
| 07/04/2013 | US20130168642 Bithiophene derivatives and semiconductor devices comprising the same |
| 07/04/2013 | CA2861202A1 Novel nicotinamide derivative or salt thereof |
| 07/03/2013 | EP2609095A2 Compounds that modulate intracellular calcium |
| 07/03/2013 | EP2609089A1 Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/03/2013 | EP2609085A1 Substituted quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609083A1 Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
| 07/03/2013 | CN103189368A Thioxanthone compound and organic light emitting element having the same |
| 07/03/2013 | CN103189363A Bisaryl-bonded aryltriazolones and use thereof |
| 07/03/2013 | CN103189361A Estrogen receptor modulators and use thereof |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN101952259B Benzodiazepine compound and pharmaceutical composition |
| 07/02/2013 | US8476455 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 07/02/2013 | US8476434 Protein kinase modulators and method of use |
| 07/02/2013 | US8476309 Benzofuran cannabinoid compounds and related methods of use |
| 07/02/2013 | US8476295 Bridged bicyclic RHO kinase inhibitor compounds, composition and use |
| 07/02/2013 | US8476274 Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators |
| 07/02/2013 | CA2539766C Benzimidazole derivates: preparation and pharmaceutical applications |
| 06/27/2013 | WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners |